Cash & equivalents increased 182.3%
Cash & equivalents changed +182.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$32.1M→$90.7M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →RLYB financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income increased 50.6%
Operating income changed +50.6% from the comparable as-filed period.
-$6.9M→-$3.4M3 prior comparisons
Revenue decreased 100.0%
Revenue changed -100.0% from the comparable as-filed period.
$212,000→$01 prior comparisons
Operating cash flow increased 65.3%
Operating cash flow changed +65.3% from the comparable as-filed period.
-$6.6M→-$2.3M3 prior comparisons
Working capital / assets moved 392 bp higher
Working capital / assets changed +392 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
91.79%→95.72%4 prior comparisons
Current ratio increased 95.8%
Current ratio changed +95.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
14.74→28.874 prior comparisons
Shares outstanding decreased 87.3%
Shares outstanding changed -87.3% from the comparable as-filed period. The change ranks at the 62th percentile of 8 prior comparable changes.
42,243,774→5,383,9378 prior comparisons
Total assets increased 41.3%
Total assets changed +41.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$67.7M→$95.6M4 prior comparisons
Working capital increased 47.3%
Working capital changed +47.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$62.1M→$91.5M4 prior comparisons
Current assets increased 42.2%
Current assets changed +42.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$66.6M→$94.8M4 prior comparisons
Research & development decreased 85.9%
Research & development changed -85.9% from the comparable as-filed period.
$4.1M→$584,0003 prior comparisons
Cash & equivalents increased 883.0%
Cash & equivalents changed +883.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$9.4M→$92.8M4 prior comparisons
Working capital / assets moved 686 bp higher
Working capital / assets changed +686 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
88.67%→95.54%4 prior comparisons
Operating cash flow changed across a sign change
Operating cash flow changed +648.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
-$8.4M→$45.9M4 prior comparisons
Current ratio increased 173.3%
Current ratio changed +173.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
9.98→27.264 prior comparisons
Operating income increased 43.8%
Operating income changed +43.8% from the comparable as-filed period.
-$10.1M→-$5.7M3 prior comparisons
Revenue decreased 100.0%
Revenue changed -100.0% from the comparable as-filed period.
$212,000→$01 prior comparisons
Research & development decreased 87.5%
Research & development changed -87.5% from the comparable as-filed period.
$6.1M→$758,0003 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.